Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians

NCT04196972 | Active Not Recruiting

• 2 other identifiers: 2019-0639NCI-2019-07565
• Study Type: interventional
• Target: 36
• Locations: 1 country
• Sites: 1

Brief Summary

This trial studies how well the Extension for Community Healthcare Outcomes (ECHO) telementoring intervention works in transforming professional engagement, practice efficiency, and community building through team meetings in diagnostic imaging clinicians. This study may help researchers learn more about the potential benefits of a model for team meetings aimed at bringing physicians together from multiple practice locations when few opportunities exist for meaningful, collegial interactions. It may also help diagnostic imaging clinicians engage more effectively with colleagues at distant sites and become more engaged with their work.

Conditions

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm

Outcome Measures

Primary Outcomes (1)

• Proportion of sessions attended

  Will be evaluated by attendance records for each session. Will estimate the attendance rate (p = proportion of participants attending at least 9 out of 13 sessions) with 95% confidence intervals.

  through study completion, an average of 1 year

Study Arms (2)

Arm A (ECHO telementoring)

EXPERIMENTAL

Participants attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

Other: Communication Intervention; Other: Questionnaire Administration

Arm B (wait-list, ECHO telementoring)

EXPERIMENTAL

Participants are placed on a wait-list for 13 weeks and then attend ECHO telementoring sessions over 1 hour weekly for 13 weeks.

Other: Communication Intervention; Other: Questionnaire Administration; Other: Waiting List

Interventions

Communication Intervention OTHER

Receive ECHO telementoring intervention

Arm A (ECHO telementoring); Arm B (wait-list, ECHO telementoring)

Questionnaire Administration OTHER

Ancillary studies

Arm A (ECHO telementoring); Arm B (wait-list, ECHO telementoring)

Waiting List OTHER

Placed on wait-list

Also known as: Waitlist

Arm B (wait-list, ECHO telementoring)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Faculty must be diagnostic imaging clinicians with a primary appointment in the Division of Diagnostic Imaging at MD Anderson

You may not qualify if:

• Faculty that have an official leadership role (Division Head or Department Chair)
• Faculty that have previously participated in any previous live ECHO clinic or ECHO activity

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• M D Anderson Cancer Center

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

Waiting Lists

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Appointments and Schedules; Organization and Administration; Health Services Administration

Study Officials

• Eduardo Bruera

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SEQUENTIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 2, 2019
• First Posted: December 12, 2019
• Study Start: August 16, 2020
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: April 15, 2026

Record last verified: 2026-04

Locations

US (1)